Opinion: Dr. Claudio Fiocchi “The need for AI-based precision therapy in inflammatory bowel disease”

Gene Network

The evolution of therapy for ulcerative colitis (UC) and Crohn’s disease (CD), the two main forms of inflammatory bowel disease (IBD), is a prolonged succession of vastly different approaches. After initial evidence of effectiveness of salazopyrine in UC patients in the 1940’s, many other medications were progressively introduced, including corticosteroids, aminosalycilates, immunosuppressors, antibiotics, and so […]